{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:28:51Z","timestamp":1762252131726},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T00:00:00Z","timestamp":1414108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00280-014-2614-6","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T20:12:23Z","timestamp":1414095143000},"page":"27-35","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections"],"prefix":"10.1007","volume":"75","author":[{"given":"Karen D.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Panetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu","family":"Onar-Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilburn E.","family":"Reddick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan","family":"Patay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Qaddoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Broniscer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giles","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick A.","family":"Boop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Paul","family":"Klimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clinton F.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,24]]},"reference":[{"key":"2614_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199306173282401","volume":"328","author":"PK Duffner","year":"1993","unstructured":"Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME et al (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725\u20131731","journal-title":"N Engl J Med"},{"key":"2614_CR2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1200\/JCO.1994.12.8.1607","volume":"12","author":"JR Geyer","year":"1994","unstructured":"Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL et al (1994) Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1\u00a0day: a report from the children\u2019s cancer group. J Clin Oncol 12:1607\u20131615","journal-title":"J Clin Oncol"},{"key":"2614_CR3","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1200\/JCO.2005.09.095","volume":"23","author":"JR Geyer","year":"2005","unstructured":"Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D et al (2005) Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the children\u2019s cancer group. J Clin Oncol 23:7621\u20137631","journal-title":"J Clin Oncol"},{"key":"2614_CR4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1200\/JCO.1994.12.6.1212","volume":"12","author":"A Gajjar","year":"1994","unstructured":"Gajjar A, Mulhern RK, Heideman RL, Sanford RA, Douglass EC, Kovnar EH et al (1994) Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 12:1212\u20131216","journal-title":"J Clin Oncol"},{"key":"2614_CR5","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1200\/JCO.1999.17.12.3720","volume":"17","author":"AW Walter","year":"1999","unstructured":"Walter AW, Mulhern RK, Gajjar A, Heideman RL, Reardon D, Sanford RA et al (1999) Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude children\u2019s research hospital. J Clin Oncol 17:3720\u20133728","journal-title":"J Clin Oncol"},{"key":"2614_CR6","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1056\/NEJMoa042176","volume":"352","author":"S Rutkowski","year":"2005","unstructured":"Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Sorensen N et al (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978\u2013986","journal-title":"N Engl J Med"},{"key":"2614_CR7","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1200\/JCO.2004.12.126","volume":"22","author":"SN Chi","year":"2004","unstructured":"Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH et al (2004) Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 22:4881\u20134887","journal-title":"J Clin Oncol"},{"key":"2614_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/pbc.22318","volume":"54","author":"SA Sands","year":"2010","unstructured":"Sands SA, Oberg JA, Gardner SL, Whiteley JA, Glade-Bender JL, Finlay JL (2010) Neuropsychological functioning of children treated with intensive chemotherapy followed by myelopablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors. Pediatr Blood Cancer 54:429\u2013436","journal-title":"Pediatr Blood Cancer"},{"key":"2614_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1200\/JCO.1988.6.4.649","volume":"6","author":"JC Allen","year":"1988","unstructured":"Allen JC, Walker R, Rosen G (1988) Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors. J Clin Oncol 6:649\u2013653","journal-title":"J Clin Oncol"},{"key":"2614_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00280-006-0388-1","volume":"59","author":"PA Thompson","year":"2007","unstructured":"Thompson PA, Murry DJ, Rosner GL, Lunagomez S, Blaney SM, Berg SL et al (2007) Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 59:847\u2013853","journal-title":"Cancer Chemother Pharmacol"},{"key":"2614_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/mpo.2950240303","volume":"24","author":"MG Donelli","year":"1995","unstructured":"Donelli MG, Zucchetti M, Robatto A, Perlangeli V, D\u2019Incalci M, Masera G et al (1995) Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia. Med Pediatr Oncol 24:154\u2013159","journal-title":"Med Pediatr Oncol"},{"key":"2614_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/1097-0142(19870701)60:1<5::AID-CNCR2820600103>3.0.CO;2-D","volume":"60","author":"JD Borsi","year":"1987","unstructured":"Borsi JD, Moe PJ (1987) A comparative study of pharmacokinetics of methotrexate in a dose range of 0.5\u00a0g to 33.6\u00a0g\/m2 in children with acute lymphoblastic leukemia. Cancer 60:5\u201313","journal-title":"Cancer"},{"key":"2614_CR13","first-page":"81","volume":"5","author":"WE Evans","year":"1987","unstructured":"Evans WE, Abromowitch M, Crom WR, Relling MV, Bowman WP, Pui CH et al (1987) Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia. NCI Monogr 5:81\u201385","journal-title":"NCI Monogr"},{"key":"2614_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0022-3476(87)80131-2","volume":"111","author":"ML Garre","year":"1987","unstructured":"Garre ML, Relling MV, Kalwinsky D, Dodge R, Crom WR, Abromowitch et al (1987) Pharmacokinetics and toxicity of methotrexate in children with down syndrome and acute lymphocytic leukemia. J Pediatr 111:606\u2013614","journal-title":"J Pediatr"},{"key":"2614_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.leu.2401673","volume":"14","author":"Wall Am","year":"2000","unstructured":"Am Wall, Gajjar A, Link A, Mahmoud H, Pui CH, Relling MV (2000) Individualized dosing in children with relapsed acute lymphoblastic leukemia. Leukemia 14:221\u2013225","journal-title":"Leukemia"},{"key":"2614_CR16","first-page":"4972","volume":"10","author":"LR Trevino","year":"2009","unstructured":"Trevino LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D et al (2009) Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetic and clinical effects. J Clin Oncol 10:4972\u20134978","journal-title":"J Clin Oncol"},{"key":"2614_CR17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cpt197823168","volume":"23","author":"WE Evans","year":"1978","unstructured":"Evans WE, Pratt CB (1978) Effect of pleural effusion on high-dose methotrexate kinetics. Clin Pharmacol Ther 23:68\u201372","journal-title":"Clin Pharmacol Ther"},{"key":"2614_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00280-004-0797-y","volume":"54","author":"JL Pauley","year":"2004","unstructured":"Pauley JL, Panetta JC, Schmidt J, Kornegay N, Relling MV, Pui CH (2004) Late-onset delayed excretion of methotrexate. Cancer Chemother Pharmacol 54:146\u2013152","journal-title":"Cancer Chemother Pharmacol"},{"key":"2614_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00280-002-0512-9","volume":"50","author":"J Li","year":"2002","unstructured":"Li J, Gwilt P (2002) The effect of malignant effusions on methotrexate disposition. Cancer Chemother Pharmacol 50:373\u2013382","journal-title":"Cancer Chemother Pharmacol"},{"key":"2614_CR20","first-page":"3487","volume":"34","author":"SH Wan","year":"1974","unstructured":"Wan SH, Huffman DH, Azarnoff DL, Stephens R, Hoogstraten B (1974) Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res 34:3487\u20133491","journal-title":"Cancer Res"},{"key":"2614_CR21","unstructured":"Monolix 3.1: User Guide 2010. \n                    http:\/\/software.monolix.org"},{"key":"2614_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1056\/NEJM199802193380803","volume":"338","author":"WE Evans","year":"1998","unstructured":"Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH (1998) Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 338:499\u2013505","journal-title":"N Engl J Med"},{"key":"2614_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FTD.0b013e318203b41e","volume":"33","author":"E Dombrowsky","year":"2011","unstructured":"Dombrowsky E, Jayaraman B, Narayan M, Barrett JS (2011) Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer. Ther Drug Monit 33:99\u2013107","journal-title":"Ther Drug Monit"},{"key":"2614_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2165\/00003088-200645120-00007","volume":"45","author":"D Aumente","year":"2006","unstructured":"Aumente D, Buelga DS, Lukas JC, Gomez P, Torres A, Garcia MJ (2006) Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. Clin Pharmacokinet 45:1227\u20131238","journal-title":"Clin Pharmacokinet"},{"key":"2614_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00280-006-0202-0","volume":"58","author":"DW Faltaos","year":"2006","unstructured":"Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan KH, Leblond V, Lechat P (2006) Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy. Cancer Chemother Pharmacol 58:626\u2013633","journal-title":"Cancer Chemother Pharmacol"},{"key":"2614_CR26","first-page":"797","volume":"61","author":"H Chan","year":"1977","unstructured":"Chan H, Evans WE, Pratt CB (1977) Recovery from toxicity associated with high-dose methotrexate: prognostic factors. Cancer Treat Rep 61:797\u2013804","journal-title":"Cancer Treat Rep"},{"key":"2614_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0090-3019(87)90286-2","volume":"27","author":"H Koizumi","year":"1987","unstructured":"Koizumi H, Fukamachi A, Nukui H (1987) Postoperative subdural fluid collections in neurosurgery. Surg Neurol 27:147\u2013153","journal-title":"Surg Neurol"},{"key":"2614_CR28","first-page":"42","volume":"9","author":"J Cabanes","year":"1978","unstructured":"Cabanes J, Vazquez R, Rivas A (1978) Hydrocephalus after posterior fossa operations. Surg Neurol 9:42\u201346","journal-title":"Surg Neurol"},{"key":"2614_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000330543","volume":"47","author":"S Eguchi","year":"2011","unstructured":"Eguchi S, Aihara Y, Hori T, Okada Y (2011) Postoperative extra-axial cerebrospinal fluid collection \u2013its pathophysiology and clinical management. Pediatr Neurosurg 47:125\u2013132","journal-title":"Pediatr Neurosurg"},{"key":"2614_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3171\/jns.2002.97.4.0821","volume":"97","author":"KK Gnanalingham","year":"2002","unstructured":"Gnanalingham KK, Lafuente J, Thompson D, Harkness W, Hayward R (2002) Surgical procedures for posterior fossa tumors in children: does carniotomy lead to fewer complications than craniectomy? J Neurosurg 97:821\u2013826","journal-title":"J Neurosurg"},{"key":"2614_CR31","first-page":"106","volume":"56","author":"RI Ernestus","year":"1995","unstructured":"Ernestus RI, Ketter G, Klug N (1995) Dura-plasty in intracranial operations. Zentralbl Neurochir 56:106\u2013110","journal-title":"Zentralbl Neurochir"},{"key":"2614_CR32","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1056\/NEJM197504172921607","volume":"292","author":"E Frei 3rd","year":"1975","unstructured":"Frei E 3rd, Jaffe N, Tattersall MH, Pitman S, Parker L (1975) New approaches to cancer chemotherapy with methotrexate. N Engl J Med 292:846\u2013851","journal-title":"N Engl J Med"},{"key":"2614_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s002800050710","volume":"41","author":"DR Gandara","year":"1997","unstructured":"Gandara DR, Edelman MJ, Crowley JJ, Lau DH, Livingston RB (1997) Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest oncology group study. Cancer Chemother Pharmacol 41:75\u201378","journal-title":"Cancer Chemother Pharmacol"},{"key":"2614_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/02841869709001295","volume":"36","author":"A Mahadevan","year":"1997","unstructured":"Mahadevan A, Kanegaonkar R, Hoskin PJ (1997) Third space sequestration increases toxicity of fludarabine: a case report. Acta Oncol 36:441","journal-title":"Acta Oncol"},{"key":"2614_CR35","unstructured":"Medline Plus: A service of the U.S. National Library of Medicine NIH National Institutes of Health: CSF total protein. \n                    http:\/\/www.nlm.nih.gov\/medlineplus\/ency\/article\/003628.htm"},{"key":"2614_CR36","unstructured":"National Cancer Institute Clinical Trials (9\/8\/2012 update) Phase III study of induction therapy comprising vincristine, high-dose methotrexate, leucovorin calcium, etoposide, cisplatin, and cyclophosphamide followed by 3-dimensional conformal radiotherapy and high-dose consolidation therapy comprising carboplatin, thiotepa, and autologous peripheral blood stem cell rescue in pediatric patients with atypical teratoid\/rhabdoid tumor of the central nervous system (ACNS0333). \n                    http:\/\/cancer.gov\/clinicaltrials\/search\/view?cdrid=592812&version=healthprofessional#StudyIdInfo_CDR0000592812"},{"key":"2614_CR37","unstructured":"National Cancer Institute Clinical Trials (9\/8\/2012 update) Phase III study of induction therapy comprising vincristine, etoposide, cyclophosphamide, and cisplatin with or without high-dose methotrexate and leucovorin calcium followed by consolidation chemotherapy comprising carboplatin and thiotepa and peripheral blood stem cell rescue in pediatric patients with newly diagnosed supratentorial primitive neuroectodermal tumors or high risk medulloblastoma. \n                    http:\/\/cancer.gov\/clinicaltrials\/search\/view?cdrid=483683&version=HealthProfessional&protocolsearchid=10902453"},{"key":"2614_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/mpo.2950250303","volume":"25","author":"CC Bailey","year":"1991","unstructured":"Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J et al (1991) Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. international society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GIOP): SIOP II. Med Pediatr Oncol 25:166\u2013178","journal-title":"Med Pediatr Oncol"},{"key":"2614_CR39","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/nor025","volume":"13","author":"AO Bueren von","year":"2011","unstructured":"von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F et al (2011) Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro-Onc 13:669\u2013679","journal-title":"Neuro-Onc"},{"key":"2614_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/pbc.21307","volume":"50","author":"J Fangusaro","year":"2008","unstructured":"Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S et al (2008) Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the head start I and II experience. Pediatr Blood Cancer 50:312\u2013318","journal-title":"Pediatr Blood Cancer"},{"key":"2614_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/pbc.21578","volume":"51","author":"SL Gardner","year":"2008","unstructured":"Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J (2008) Intensive induction chemotherapy followed by high dose chemotherapy with autologous heamtopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 51:235\u2013240","journal-title":"Pediatr Blood Cancer"},{"key":"2614_CR42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0022-3476(78)80133-4","volume":"92","author":"BS Arant Jr","year":"1978","unstructured":"Arant BS Jr (1978) Developmental patterns of renal function maturation compared in the human neonate. J Pediatr 92:705\u2013712","journal-title":"J Pediatr"},{"key":"2614_CR43","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2165\/00003088-200241130-00005","volume":"41","author":"J Alcorn","year":"2002","unstructured":"Alcorn J, McNamara PJ (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants. Clin Pharmacokinet 41:1077\u20131094","journal-title":"Clin Pharmacokinet"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2614-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2614-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2614-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2614-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T22:41:20Z","timestamp":1581979280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2614-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,24]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2614"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2614-6","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,24]]},"assertion":[{"value":"9 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}